Exclusive

Publication

Byline

Location

Is India forever a generics-only player?

India, Feb. 18 -- When the Indian Patent Office rejected multinational conglomerate (MNC) AbbVie's patent application for its cancer drug Venetoclax in late January, there was customary cheerleading t... Read More


India is facing up to its innovation lag

India, Feb. 3 -- Coming of age can be traumatic. It involves a journey of discovery when youngsters come face to face with the adult world and its many challenges while coping with the inadequacies of... Read More